Ms. Carlson began her career as a microbiological research technician at the University of Minnesota Department of Veterinary Pathobiology. She then went on to develop diagnostic laboratory methods and swine vaccines for Oxford Veterinary Laboratories. After the acquisition of Oxford Veterinary Laboratories by the Upjohn company, she developed a specialization in the areas of Quality Control and Regulatory Affairs. In 1993 Ms. Carlson joined Solvay Animal Health as Director of Veterinary Biologics Regulatory Affairs. When Wyeth’s Fort Dodge Animal Health Division purchased Solvay Animal Health, she became Director of U. S. Regulatory Affairs for the merged company, and later was named Senior Director of Global Biological Animal Health Regulatory Affairs for Fort Dodge Animal Health. At the same time she served as team leader for reference requalification, and also served on key QA committees for US and International biological product change management. Ms. Carlson headed an independent consulting practice from 2006 until joining Benchmark Biolabs, Inc. in 2011.

Ms. Carlson has served as Chairman of the Animal Health Institute Biologics Section Regulatory Committee, and was recently an invited speaker at an Association of Veterinary Biologics conference. She has managed over 100 successful registration and licensing campaigns involving veterinary biological products intended for use in all major domestic animal species, both full and conditional, for the US and export markets. Ms. Carlson is also experienced in autogenous product regulatory and quality issues. Ms. Carlson is an experienced trainer and continues to host various nationally recognized veterinary biologics training seminars throughout the year.